ImageneBio Inc (IMA) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

ImageneBio Inc (IMA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $66.9M, listed on NASDAQ, employing roughly 10 people, carrying a beta of 0.74 to the broader market. Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis Led by Kristin Yarema, public since 1998-02-27.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for IMA as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →